Simplex Trading
ORKA

Simplex Trading’s Oruka Therapeutics ORKA Stock Holding History

Simplex Trading’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
11,000
-8,300
-43% -$553K ﹤0.01% 2727
2026
Q1 		$947K Buy
19,300
+19,100
+9,550% +$664K ﹤0.01% 2554
2025
Q4 		$6.06K Sell
200
-9,500
-98% -$265K ﹤0.01% 7321
2025
Q3 		$186K Buy
+9,700
New +$144K ﹤0.01% 5026
2023
Q2 		– Sell
-600
Closed -$14K – 10136
2023
Q1 		$14K Buy
600
+417
+228% +$11K ﹤0.01% 7274
2022
Q4 		$5K Sell
183
-409
-69% -$10.5K ﹤0.01% 8120
2022
Q3 		$14K Sell
592
-741
-56% -$20.9K ﹤0.01% 7939
2022
Q2 		$39K Buy
1,333
+950
+248% +$26.9K ﹤0.01% 6831
2022
Q1 		$10K Buy
383
+200
+109% +$4.96K ﹤0.01% 8915
2021
Q4 		$4K Sell
183
-859
-82% -$25.9K ﹤0.01% 9736
2021
Q3 		$43K Hold
1,042
– – ﹤0.01% 7700
2021
Q2 		$43K Buy
1,042
+1,038
+25,950% +$43.3K ﹤0.01% 7840
2021
Q1 		$17K Buy
+4
New +$210 ﹤0.01% 7600

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Simplex Trading's ORKA Position: Q2 2026 in Review

Simplex Trading sold out of Oruka Therapeutics (ORKA) in Q2 2026, closing a stake of 2,463 shares — an estimated $164K sold.

Simplex Trading first reported a position in ORKA in Q4 2020 and held it in 10 quarters. The position peaked at $121K in Q1 2026. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Simplex Trading reported no remaining Oruka Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 2,463 Oruka Therapeutics shares in Q2 2026, an estimated $164K.
  • Simplex Trading first reported a position in Oruka Therapeutics in Q4 2020 and held it in 10 quarters.
  • Simplex Trading's Oruka Therapeutics position peaked at $121K in Q1 2026.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.